Shareholder Alert: Faruqi & Faruqi LLP Investigates MoonLake Immunotherapeutics The Unfolding Story of MoonLake: Shareholder Ire and a Looming Deadline MoonLake Immunotherapeutics Skyrockets: Is a Biotech Buyout Imminent After Breakthrough Skin Drug Trial?